voriconazole has been researched along with Cystic Fibrosis of Pancreas in 48 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (22.92) | 29.6817 |
| 2010's | 34 (70.83) | 24.3611 |
| 2020's | 3 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Müller, FM; Salvenmoser, S; Seidler, MJ | 1 |
| Marsh, JJ; Sabino, R; Sass, G; Shrestha, P; Stevens, DA | 1 |
| Brito Devoto, T; Cuestas, ML; Finquelievich, JL; García-Effrón, G; Hermida-Alva, K; Posse, G | 1 |
| Epps, KL; Epps, QJ; Young, DC; Zobell, JT | 1 |
| Hanretty, AM; Langelier, C; Trang, TP; Yang, K | 1 |
| Ladak, K; Rubin, L | 1 |
| Abela, IA; Benden, C; Imkamp, F; Mueller, NJ; Muller, F; Murer, C; Schmitt, JW; Schuurmans, MM | 1 |
| Chakrabarti, A; Kaur, H; Rudramurthy, SM; Singh, M; Singh, S | 1 |
| Bongomin, F; Hassanzad, M; Hedayati, MT; Hedayati, N; Maleki, M; Mortezaee, V; Poorabdollah, M; Sharifynia, S; Velayati, AA | 1 |
| Chapin, RW; Elmore, S; Silver, RM; Whelan, TP; Wisse, A | 1 |
| Chen, SC; Meyer, W; Middleton, PG | 1 |
| Clements, RM; Estrada, L; Jon, CK; Mosquera, RA | 1 |
| Holle, J; Leichsenring, M; Meissner, PE | 1 |
| Guo, D; Hawryluk, EB; Huang, JT; London, WB; Sheu, J | 1 |
| Bromley, MJ; Denning, DW | 1 |
| Dominique, S; Favennec, L; Gargala, G; Lavergne, RA; Le Pape, P; Meis, JF; Morio, F; Verweij, PE | 1 |
| Cerar, T; Krivec, U; Matos, T; Pirš, M; Praprotnik, M | 1 |
| Cunningham, L; Gallagher, C; Keating, C; Lally, A; McKone, E; Moran, M | 1 |
| Liu, J; Wang, W; Xu, H; Zhao, S; Zhao, Y | 1 |
| Clemons, KV; Hernandez, C; Martinez, M; Moss, RB; Stevens, DA | 1 |
| Ansquer, C; Berthelot, JM; Bode-Milin, C; Haloun, A; Maugars, Y; Metayer, B | 1 |
| Augustynowicz-Kopeć, E; Garczewska, B; Jarzynka, S; Kuś, J; Skorupa, W | 1 |
| Buer, J; Dittmer, S; Haase, G; Kirchhoff, L; Olsowski, M; Rath, PM; Sedlacek, L; Steinmann, E; Steinmann, J; Zilmans, K | 1 |
| Elnazir, B; Glackin, L; Greally, P; Leen, G | 1 |
| Amrein, C; Batisse, A; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Dannaoui, E; Guillemain, R; Lillo-Le Louet, A; Loriot, MA; Pham, MH | 1 |
| Amrein, C; Benammar, M; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Guillemain, R; Lefeuvre, S | 1 |
| Begué, D; Billaud, E; Boussaud, V; Caruba, T; Guillemain, R; Korb, V; Prognon, P; Sabatier, B; Thomas, A | 1 |
| Bouchara, JP; Danner-Boucher, I; Despins, P; Gay-Andrieu, F; Haloun, A; Horeau-Langlard, D; Jossic, F; Le Pape, P; Miegeville, M; Morio, F; Nourry, L; Pattier, S; Talarmin, JP; Treilhaud, M | 1 |
| Cooperstock, MS; Griffard, EA; Guajardo, JR; Scoville, CL | 1 |
| Cheng, MP; Lands, LC; Ovetchkine, P; Paquette, K; Quach, C; Théoret, Y | 1 |
| Amrein, C; Beaune, PH; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Guillemain, R; Laurent-Puig, P; Le Beller, C; Lillo-Lelouet, A; Loriot, MA; Trégouet, DA | 1 |
| Borghi, E; Iatta, R; Manca, A; Montagna, MT; Morace, G | 1 |
| Garcia-Hermoso, D; Gay-Andrieu, F; Haloun, A; Le Pape, P; Leclair, F; Lepoivre, T; Miegeville, M; Miossec, C; Morio, F; Treilhaud, M | 1 |
| Clifton, IJ; Conway, SP; Metcalfe, R; Peckham, DG; Phillip, M; Shaw, N; Whitaker, P | 1 |
| Doudounakis, S; Katelari, A; Markantonis, SL; Pappa, E | 1 |
| Bermudez, C; Bhama, JK; Clancy, CJ; Crespo, MM; Kwak, EJ; Mitsani, D; Nguyen, MH; Pilewski, JM; Shields, RK; Silveira, FP; Toyoda, Y | 1 |
| Couderc, L; Dominique, S; Favennec, L; Leguillon, C; Marguet, C; Masseline, B; Pramil, S; Rondeau, S | 1 |
| Aubin, GG; Bretagne, S; Danner-Boucher, I; Garcia-Hermoso, D; Haloun, A; Le Pape, P; Miegeville, M; Morio, F; Sacchetto, E | 1 |
| Balfour-Lynn, IM; Bentley, S; Gupta, A | 1 |
| Buer, J; Dittmer, S; Hamprecht, A; Lackner, M; Rath, PM; Schemuth, H; Sedlacek, L; Steinmann, E; Steinmann, J | 1 |
| Atalay, MA; Koç, N; Sav, H; Unal, E | 1 |
| Brown, NE; Chow, L; Kunimoto, D | 1 |
| Balfour-Lynn, I; Buchdahl, R; Bush, A; Davies, J; Edwards, S; Francis, J; Hilliard, T; Rosenthal, M | 1 |
| Schoeni, MH | 1 |
| Conte, JV; Dropulic, LK; Girgis, R; Mcdyer, JF; Orens, JB; Shlobin, OA; Yang, SY | 1 |
| Denis, O; Estenne, M; Jacobs, F; Knoop, C; Nolard, N; Schrooyen, M; Symoens, F | 1 |
| Alioua, D; Anract, P; Dougados, M; Dupont, B; Guerini, H; Guignard, S; Hubert, D; Paugam, A | 1 |
| Diemert, D; Kunimoto, D; Rennie, R; Sand, C | 1 |
5 review(s) available for voriconazole and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
A cluster of scedosporiosis in lung transplant candidates and recipients: The Zurich experience and review of the literature.
Topics: Adult; Antifungal Agents; Cystic Fibrosis; Female; Humans; Lung Transplantation; Male; Mycetoma; Mycoses; Scedosporium; Switzerland; Transplant Recipients; Voriconazole; Young Adult | 2018 |
Voriconazole-associated periostitis presenting as hypertrophic osteoarthropathy following lung transplantation report of two cases and review of the literature.
Topics: Adult; Antifungal Agents; Cystic Fibrosis; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Lung Transplantation; Male; Middle Aged; Osteoarthropathy, Secondary Hypertrophic; Periostitis; Postoperative Complications; Voriconazole | 2019 |
Fungal infections and treatment in cystic fibrosis.
Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Bronchoalveolar Lavage Fluid; Candida; Candidiasis; Cystic Fibrosis; DNA, Fungal; Female; Humans; Itraconazole; Male; Pyrimidines; Scedosporium; Sputum; Triazoles; Vital Capacity; Voriconazole | 2013 |
Nebulized voriconazole in infections with Scedosporium apiospermum--case report and review of the literature.
Topics: Administration, Inhalation; Adolescent; Antifungal Agents; Bronchoalveolar Lavage Fluid; Cystic Fibrosis; Diagnosis, Differential; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Immunocompromised Host; Lung Diseases, Fungal; Male; Nebulizers and Vaporizers; Scedosporium; Tomography, X-Ray Computed; Voriconazole | 2014 |
[Allergic bronchopulmonary aspergillosis: a report of four cases with literature review].
Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Asthma; Bronchiectasis; Child; Cough; Cystic Fibrosis; Humans; Pulmonary Atelectasis; Retrospective Studies; Thorax; Tomography, X-Ray Computed; Voriconazole | 2015 |
2 trial(s) available for voriconazole and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
Pharmacokinetics of oral voriconazole in patients with cystic fibrosis.
Topics: Administration, Oral; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cystic Fibrosis; Female; Humans; Male; Pyrimidines; Triazoles; Voriconazole | 2011 |
Voriconazole pharmacokinetics and photosensitivity in children with cystic fibrosis.
Topics: Administration, Oral; Adolescent; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Child; Cystic Fibrosis; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Prospective Studies; Pyrimidines; Sunlight; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2012 |
41 other study(ies) available for voriconazole and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biofilms; Bronchi; Cells, Cultured; Cystic Fibrosis; Drug Resistance, Fungal; Epithelial Cells; Humans; Microbial Sensitivity Tests; Microscopy, Confocal; Microscopy, Electron, Scanning; Respiratory Tract Infections | 2008 |
Synergy Between
Topics: Aspergillus fumigatus; Biofilms; Coinfection; Cystic Fibrosis; Humans; Pseudomonas aeruginosa; Voriconazole | 2022 |
Antifungal susceptibility patterns for Aspergillus, Scedosporium, and Exophiala isolates recovered from cystic fibrosis patients against amphotericin B, and three triazoles and their impact after long-term therapies.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Azoles; Cystic Fibrosis; Exophiala; Itraconazole; Scedosporium; Triazoles; Voriconazole | 2023 |
Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: II. Therapies for allergic bronchopulmonary aspergillosis.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Amphotericin B; Anti-Infective Agents; Antibodies, Monoclonal; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Child; Cystic Fibrosis; Female; Humans; Itraconazole; Omalizumab; Voriconazole | 2020 |
Use of isavuconazole in a patient with voriconazole-induced QTc prolongation.
Topics: Antifungal Agents; Cystic Fibrosis; Female; Humans; Long QT Syndrome; Lung Transplantation; Nitriles; Pyridines; Triazoles; Voriconazole; Young Adult | 2017 |
Voriconazole-Induced Periostitis Deformans: A Mimicker of Hypertrophic Pulmonary Osteoarthropathy.
Topics: Adult; Cystic Fibrosis; Humans; Lung Transplantation; Male; Osteoarthropathy, Primary Hypertrophic; Periostitis; Pulmonary Aspergillosis; Voriconazole | 2017 |
Aspergillus terreus Causing Probable Invasive Aspergillosis in a Patient with Cystic Fibrosis.
Topics: Antifungal Agents; Aspergillus; Child; Cystic Fibrosis; Drug Monitoring; Galactose; Humans; India; Invasive Pulmonary Aspergillosis; Male; Mannans; Treatment Outcome; Voriconazole | 2019 |
Successful control of exacerbation of Allergic Bronchopulmonary Aspergillosis due to Aspergillus terreus in a cystic fibrosis patient with short-term adjunctive therapy with voriconazole: A case report.
Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Child; Cystic Fibrosis; Drug Administration Schedule; Humans; Itraconazole; Male; Sputum; Thorax; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole | 2019 |
Early diagnosis and treatment of invasive pulmonary aspergillosis in a patient with cystic fibrosis.
Topics: Antifungal Agents; beta-Glucans; Biomarkers; Bronchoalveolar Lavage; Child; Cystic Fibrosis; Early Diagnosis; Fatal Outcome; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Mannans; Pyrimidines; Triazoles; Voriconazole | 2013 |
Voriconazole phototoxicity in children: a retrospective review.
Topics: Adolescent; Antifungal Agents; Boston; Carcinoma, Squamous Cell; Causality; Child; Comorbidity; Cystic Fibrosis; Dermatitis, Phototoxic; Female; Humans; Immunocompromised Host; Incidence; Male; Mycoses; Retrospective Studies; Risk Factors; Skin Neoplasms; Voriconazole; White People | 2015 |
Infectious Disease. How to bolster the antifungal pipeline.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Asthma; Cystic Fibrosis; Drug Design; Drug Resistance, Fungal; Humans; Pulmonary Disease, Chronic Obstructive; Voriconazole | 2015 |
First description of azole-resistant Aspergillus fumigatus due to TR46/Y121F/T289A mutation in France.
Topics: Anti-Bacterial Agents; Antibodies, Fungal; Aspergillosis; Aspergillus fumigatus; Azoles; Cystic Fibrosis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Europe; France; Fungal Proteins; Humans; Immunoglobulin E; Itraconazole; Male; Mutation; Retrospective Studies; Voriconazole; Young Adult | 2015 |
First recovery of Rasamsonia argillacea species complex isolated in adolescent patient with cystic fibrosis in Slovenia--case report and review of literature.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Cystic Fibrosis; Echinocandins; Eurotiales; Humans; Lipopeptides; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Pharynx; Sequence Analysis, DNA; Slovenia; Voriconazole; Young Adult | 2015 |
Recall of provision of sun protection measures to patients with cystic fibrosis being prescribed voriconazole.
Topics: Adult; Antifungal Agents; Carcinoma, Squamous Cell; Cystic Fibrosis; Dermatitis, Phototoxic; Female; Humans; Male; Middle Aged; Patient Education as Topic; Pulmonary Aspergillosis; Skin Neoplasms; Sunburn; Sunlight; Voriconazole; Young Adult | 2015 |
Effect of Media Modified To Mimic Cystic Fibrosis Sputum on the Susceptibility of Aspergillus fumigatus, and the Frequency of Resistance at One Center.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biomimetic Materials; Cystic Fibrosis; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Sputum; Voriconazole | 2016 |
Painful and swollen hands 3 months after lungs graft: Suracute voriconazole-induced periostitis and exostosis.
Topics: Antifungal Agents; Arthralgia; Cystic Fibrosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Edema; Follow-Up Studies; Hand; Humans; Lung Transplantation; Male; Middle Aged; Periostitis; Postoperative Period; Radionuclide Imaging; Risk Assessment; Severity of Illness Index; Voriconazole | 2017 |
Fungal infection of cystic fibrosis patients - single center experience.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Candida albicans; Candida tropicalis; Cystic Fibrosis; Drug Resistance, Multiple, Fungal; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Scedosporium; Triazoles; Voriconazole; Yeasts | 2016 |
Biofilm formation of the black yeast-like fungus Exophiala dermatitidis and its susceptibility to antiinfective agents.
Topics: Antifungal Agents; Bacterial Adhesion; beta-Glucans; Biofilms; Catechin; Colistin; Cystic Fibrosis; Echinocandins; Exophiala; Farnesol; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Voriconazole | 2017 |
Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis.
Topics: Adolescent; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Confidence Intervals; Cystic Fibrosis; Female; Forced Expiratory Volume; Humans; Immunoglobulin E; Male; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2009 |
Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Cystic Fibrosis; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Female; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Mycoses; Pyrimidines; Scedosporium; Tacrolimus; Triazoles; Voriconazole; Young Adult | 2009 |
Safe management of tacrolimus together with posaconazole in lung transplant patients with cystic fibrosis.
Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Cystic Fibrosis; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Female; Graft Rejection; Humans; Immunosuppressive Agents; Itraconazole; Lung Transplantation; Male; Microbial Sensitivity Tests; Mycoses; Prescriptions; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2009 |
Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillus; Caspofungin; Cystic Fibrosis; Drug Interactions; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Lipopeptides; Lung Transplantation; Male; Middle Aged; Pyrimidines; Retrospective Studies; Tacrolimus; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2010 |
Disseminated Scedosporium/Pseudallescheria infection after double-lung transplantation in patients with cystic fibrosis.
Topics: Adult; Antifungal Agents; Brain; Caspofungin; Chemoprevention; Cystic Fibrosis; DNA, Fungal; Echinocandins; Fatal Outcome; Female; Humans; Lipopeptides; Lung Diseases, Fungal; Lung Transplantation; Magnetic Resonance Imaging; Microbial Sensitivity Tests; Microscopy; Molecular Sequence Data; Naphthalenes; Pseudallescheria; Pyrimidines; Radiography; RNA, Fungal; RNA, Ribosomal, 28S; Scedosporium; Sequence Analysis, DNA; Terbinafine; Triazoles; Voriconazole | 2010 |
Isolation of Exophiala dermatitidis from pigmented sputum in a cystic fibrosis patient.
Topics: Adolescent; Adrenal Cortex Hormones; Antifungal Agents; Cystic Fibrosis; Exophiala; Female; Humans; Lung Diseases, Fungal; Mycoses; Pyrimidines; Recurrence; Sputum; Triazoles; Voriconazole | 2010 |
Voriconazole inhibition of vitamin A metabolism: are adverse events increased in cystic fibrosis patients?
Topics: Adolescent; Antifungal Agents; Child; Cohort Studies; Cystic Fibrosis; Dietary Supplements; Female; Humans; Male; Photosensitivity Disorders; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Vision Disorders; Vitamin A; Voriconazole | 2010 |
Effect of cytochrome P450 2C19 genotype on voriconazole exposure in cystic fibrosis lung transplant patients.
Topics: Adolescent; Adult; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Cystic Fibrosis; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Female; Genotype; Humans; Lung Transplantation; Male; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2011 |
Chronic airway colonization by Scedosporium apiospermum with a fatal outcome in a patient with cystic fibrosis.
Topics: Adult; Antifungal Agents; Cystic Fibrosis; Fatal Outcome; Humans; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Mycetoma; Pyrimidines; Random Amplified Polymorphic DNA Technique; Scedosporium; Triazoles; Voriconazole | 2010 |
Fatal invasive infection with fungemia due to Microascus cirrosus after heart and lung transplantation in a patient with cystic fibrosis.
Topics: Adult; Antifungal Agents; Ascomycota; Caspofungin; Cystic Fibrosis; DNA, Fungal; Echinocandins; Fatal Outcome; Fungemia; Heart Transplantation; Histocytochemistry; Humans; Immunocompromised Host; Lipopeptides; Lung Transplantation; Male; Microscopy; Molecular Sequence Data; Mycoses; Pleura; Pyrimidines; Radiography, Thoracic; Sequence Analysis, DNA; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2011 |
Prospective, observational study of voriconazole therapeutic drug monitoring among lung transplant recipients receiving prophylaxis: factors impacting levels of and associations between serum troughs, efficacy, and toxicity.
Topics: Adult; Aged; Antifungal Agents; Central Nervous System; Chromatography, High Pressure Liquid; Cystic Fibrosis; Drug Monitoring; Female; Fungi; Humans; Liver; Lung; Lung Transplantation; Male; Middle Aged; Mycoses; Prospective Studies; Pulmonary Fibrosis; Pyrimidines; Treatment Outcome; Triazoles; United States; Voriconazole | 2012 |
High frequency of voriconazole-related phototoxicity in cystic fibrosis patients.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Dermatitis, Phototoxic; Female; Humans; Male; Pyrimidines; Severity of Illness Index; Triazoles; Voriconazole; Young Adult | 2012 |
High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Drug Resistance, Fungal; France; Humans; In Vitro Techniques; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Pyrimidines; Retrospective Studies; Sequence Analysis, DNA; Triazoles; Tubulin; Voriconazole; Young Adult | 2012 |
Subtherapeutic itraconazole and voriconazole levels in children with cystic fibrosis.
Topics: Adolescent; Antifungal Agents; Child; Cystic Fibrosis; Humans; Itraconazole; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2013 |
In vitro activity of colistin as single agent and in combination with antifungals against filamentous fungi occurring in patients with cystic fibrosis.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Colistin; Cystic Fibrosis; Drug Evaluation, Preclinical; Drug Synergism; Echinocandins; Exophiala; Humans; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2013 |
[The importance of bronchoalveolar lavage sample for galactomannan, 1,3-ß-d-glucan and PCR tests].
Topics: Antifungal Agents; beta-Glucans; Bronchoalveolar Lavage Fluid; Bronchoscopy; Child; Cystic Fibrosis; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lymphoma, Large B-Cell, Diffuse; Male; Mannans; Pyrimidines; Real-Time Polymerase Chain Reaction; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2012 |
An unusual case of pulmonary invasive aspergillosis and aspergilloma cured with voriconazole in a patient with cystic fibrosis.
Topics: Adult; Antifungal Agents; Aspergillosis; Cystic Fibrosis; Female; Humans; Lung Diseases, Fungal; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2002 |
Voriconazole therapy in children with cystic fibrosis.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Lung Diseases, Fungal; Male; Pyrimidines; Retrospective Studies; Sputum; Statistics, Nonparametric; Treatment Outcome; Triazoles; Voriconazole | 2005 |
To treat or not to treat with antifungal agents?
Topics: Adolescent; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Lung Diseases, Fungal; Male; Pyrimidines; Sputum; Triazoles; Voriconazole | 2005 |
Mediastinal mass due to Aspergillus fumigatus after lung transplantation: a case report.
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cystic Fibrosis; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Female; Humans; Immunocompromised Host; Lipopeptides; Lung Transplantation; Magnetic Resonance Imaging; Mediastinal Diseases; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Recurrence; Thoracoscopy; Triazoles; Voriconazole | 2005 |
Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation.
Topics: Adult; Antifungal Agents; Bronchi; Chorioretinitis; Cystic Fibrosis; Fatal Outcome; Female; Humans; Immunocompromised Host; Lung Transplantation; Meningitis, Fungal; Mycetoma; Pyrimidines; Scedosporium; Sputum; Triazoles; Voriconazole | 2006 |
Multifocal Scedosporium apiospermum spondylitis in a cystic fibrosis patient.
Topics: Adult; Antifungal Agents; Caspofungin; Cystic Fibrosis; Drug Therapy, Combination; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Male; Mycetoma; Pleurisy; Pyrimidines; Scedosporium; Spondylitis; Thoracic Vertebrae; Triazoles; Voriconazole | 2008 |
Sputum isolation of Wangiella dermatitidis in patients with cystic fibrosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Cystic Fibrosis; Exophiala; Female; Hemoptysis; Humans; Lung Diseases, Fungal; Magnetic Resonance Imaging; Pyrimidines; Sputum; Triazoles; Voriconazole | 2001 |